1. Home
  2. DENN vs DSGN Comparison

DENN vs DSGN Comparison

Compare DENN & DSGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DENN
  • DSGN
  • Stock Information
  • Founded
  • DENN 1953
  • DSGN 2017
  • Country
  • DENN United States
  • DSGN United States
  • Employees
  • DENN N/A
  • DSGN N/A
  • Industry
  • DENN Restaurants
  • DSGN Biotechnology: Pharmaceutical Preparations
  • Sector
  • DENN Consumer Discretionary
  • DSGN Health Care
  • Exchange
  • DENN Nasdaq
  • DSGN Nasdaq
  • Market Cap
  • DENN 203.4M
  • DSGN 208.9M
  • IPO Year
  • DENN 1989
  • DSGN 2021
  • Fundamental
  • Price
  • DENN $3.95
  • DSGN $3.97
  • Analyst Decision
  • DENN Strong Buy
  • DSGN Hold
  • Analyst Count
  • DENN 6
  • DSGN 1
  • Target Price
  • DENN $7.46
  • DSGN $4.00
  • AVG Volume (30 Days)
  • DENN 611.8K
  • DSGN 104.9K
  • Earning Date
  • DENN 08-04-2025
  • DSGN 08-04-2025
  • Dividend Yield
  • DENN N/A
  • DSGN N/A
  • EPS Growth
  • DENN N/A
  • DSGN N/A
  • EPS
  • DENN 0.33
  • DSGN N/A
  • Revenue
  • DENN $453,997,000.00
  • DSGN N/A
  • Revenue This Year
  • DENN $7.51
  • DSGN N/A
  • Revenue Next Year
  • DENN $1.98
  • DSGN N/A
  • P/E Ratio
  • DENN $12.01
  • DSGN N/A
  • Revenue Growth
  • DENN N/A
  • DSGN N/A
  • 52 Week Low
  • DENN $2.85
  • DSGN $2.60
  • 52 Week High
  • DENN $7.73
  • DSGN $7.77
  • Technical
  • Relative Strength Index (RSI)
  • DENN 44.45
  • DSGN 55.13
  • Support Level
  • DENN $3.80
  • DSGN $3.95
  • Resistance Level
  • DENN $4.48
  • DSGN $4.34
  • Average True Range (ATR)
  • DENN 0.20
  • DSGN 0.27
  • MACD
  • DENN -0.05
  • DSGN 0.04
  • Stochastic Oscillator
  • DENN 20.88
  • DSGN 73.27

About DENN Denny's Corporation

Denny's Corp is one of America's franchised full-service restaurant chains based on the number of restaurants. The company owns and operates the Denny's brand and the Keke's Breakfast Cafe brand. It provides Pancakes, Appetizers & Soups, Sandwiches & Salads, Breakfast Melts, Omelets, and others. The company generates its revenue from two sources: the sale of food and beverages and the collection of royalties, advertising revenue, initial and other fees, including occupancy revenue, from restaurants operated by their franchisees.

About DSGN Design Therapeutics Inc.

Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. The Company's product candidate is in Friedreich ataxia (FA), its second product candidate is in Fuchs endothelial corneal dystrophy (FECD), and it is also advancing its GeneTACTM program to address other serious nucleotide repeat-driven monogenic diseases.

Share on Social Networks: